Targeting androgen receptor in glioblastoma.

Gan, Xia; Liu, Yonghong; Wang, Xueni

Gan, Xia; Liu, Yonghong; Wang, Xueni.

Afiliación

Gan X; Guangxi Zhuang Yao Medicine Center of Engineering and Technology, Guangxi University of Chinese Medicine, 13 Wuhe Road, Qingxiu District, Nanning 530200, China; Guangxi key laboratory of marine drugs, Institute of marine drugs, Guangxi University of Chinese Medicine, 13 Wuhe Road, Qingxiu District, Nanning 530200, China.
Liu Y; Guangxi key laboratory of marine drugs, Institute of marine drugs, Guangxi University of Chinese Medicine, 13 Wuhe Road, Qingxiu District, Nanning 530200, China. Electronic address: yonghongliu@scsio.ac.cn.
Wang X; Guangxi Zhuang Yao Medicine Center of Engineering and Technology, Guangxi University of Chinese Medicine, 13 Wuhe Road, Qingxiu District, Nanning 530200, China; Guangxi key laboratory of marine drugs, Institute of marine drugs, Guangxi University of Chinese Medicine, 13 Wuhe Road, Qingxiu District, Nanning 530200, China. Electronic address: wangxueni@gxtcmu.edu.cn.

Crit Rev Oncol Hematol ; 191: 104142, 2023 Nov.

Article en En | MEDLINE | ID: mdl-37742885

Palabras clave

5α-Reductase; 5α-Reductase inhibitor; Androgen receptor; Androgen receptor antagonists; Epidermal growth factor receptor; Glioblastoma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Crit Rev Oncol Hematol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google